2-Year U.S. Treasury Note Continuous Contract $101.754 0.129 0.13% 5-Year U.S. Treasury Note Continuous Contract $105.742 0.336 0.32% 10-Year U.S. Treasury Note Continuous Contract $108.859 0.500 ...
2-Year U.S. Treasury Note Continuous Contract $101.605-0.020-0.02% 5-Year U.S. Treasury Note Continuous Contract $105.344-0.063-0.06% 10-Year U.S. Treasury Note Continuous Contract $108.234-0.125 ...
which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing ...